Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03547687 · ClinicalTrials.gov registry record · NA
Neurosciences-Intensive Care Unit Electrical Stimulation
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03547687 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 9 participants.
The verdict
NCT03547687, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Patients admitted to the Neurosciences Intensive Care Unit (NSICU) are at particular risk of developing ICU-associated weakness and myopathy, given the unique risks of early mobilization in these patients, which include increased intracranial pressure, hemodynamic instability, vasospasm, decreased cerebral blood flow with resultant cerebral ischemia, and delirium. Interventions that could provide some of the benefits of early mobilization without these risks would be of great utility in the NSICU. A number of studies have demonstrated that electrical stimulation of the lower extremity muscles, generally the quadriceps, can retard disuse atrophy and loss of strength associated with medical ICU stays, and one study has shown reduced length of intubation and accelerated functional recovery. This pilot trial will evaluate the impact of electrical stimulation on patients in the NSICU, with a hypothesis that electrical stimulation treatments will reduce the length of hospital stay and intubation and improve functional recovery. In this trial, intubated patients admitted to the NSICU will have electrical stimulation applied to the quadriceps muscle groups on both lower extremities simultaneously for 45 minutes at a time for a total of 5 treatments each week, for up to 14 days or until ICU discharge, whichever comes first.
Interventions
- DEVICE Electrical Stimulation Treatment
- DEVICE Neuromuscular Electrical Stimulation Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-08-10 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03547687
The ClinicalTrials.gov registry entry for NCT03547687 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electrical Stimulation Treatment is the first listed.
NCT03547687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03547687 about?
NCT03547687 is a clinical study titled "Neurosciences-Intensive Care Unit Electrical Stimulation". Patients admitted to the Neurosciences Intensive Care Unit (NSICU) are at particular risk of developing ICU-associated weakness and myopathy, given the unique risks of early mobilization in these patients, which include increased intracranial pressure, hemodynamic instability, vasospasm, decreased c...
What is the current status of trial NCT03547687?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2018-08-10. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03547687?
The interventions under investigation include: Electrical Stimulation Treatment (DEVICE), Neuromuscular Electrical Stimulation Treatment (DEVICE).
Who is sponsoring clinical trial NCT03547687?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.